Terflu lar menthol tab suckable 1mg 2mg + 20 units

Description

Composition
Active substance:
cetylpyridinium chloride, 2 mg; lidocaine hydrochloride 1 mg;
Excipients:
oil of peppermint leaves chernolistnoy – 0.5 mg, oil of peppermint leaves Schimmel – 0.5 mg, levomenthol – 6 mg, acesulfame potassium – 6 mg corn starch – 55 mg citric acid monohydrate – 5 mg Macrogol 6000 – 25 mg microcrystalline cellulose (Avicel PH-105) – 20 mg magnesium stearate – 2 mg sorbitol (Karion 3140) – 1107 mg.
Description:
Lozenges (menthol), white, rectangular with beveled edges, with the odor of menthol.
Product form:
10 tablets in the blister of a three-layer composite of PVC / PE / PVDC and aluminum foil. 2 blisters together with instructions for use placed in a cardboard box.
Contraindications
I trimester of pregnancy; breastfeeding; Children under 6 years of age; deficit sucrase / isomaltase, fructose intolerance, glucose-galactose malabsorption; hypersensitivity to the drug. Precautions: open wounds of the oral mucosa.
Dosage
1 mg + 2mg
Indications
Infectious and inflammatory diseases of the oral cavity and throat: pharyngitis; laryngitis; catarrhal angina; stomatitis; ulcerative gingivitis; tonsillitis (as an adjuvant).
Interaction with other drugs
Drug interaction Teraflyu® LAR formulation Menthol is not revealed.
Overdose
Symptoms at random taking the drug (as well as other ammonium compounds) in high doses may be nausea and vomiting. The content of lidocaine preparation is insignificant and can not cause serious overdose symptoms. Treatment: stop taking the drug; recommended milk drink or eat egg white, whipped in the water.
pharmachologic effect
Pharmacological group:
R02A
Pharmacodynamics:
Combined topical antiseptic and contains local anesthetic. Cetylpyridinium chloride – preservative from the group consisting of quaternary ammonium compounds has bactericidal activity against Gram-positive and to a lesser extent Gram-negative bacteria. Alters the permeability of the cytoplasmic membrane of bacteria, violates the internal oxidation of breathing mechanisms of bacteria that leads to their death. Cetylpyridinium chloride has antifungal and antiviral activity against enveloped viruses. Lidocaine hydrochloride – local anesthetic of the amide groups reduces pain in the throat when swallowing in inflammatory processes. Lidocaine gives cell membrane permeability to sodium ions, which leads to anesthesia as a result of blockade of nerve impulses.
Pharmacokinetics:
Cetylpyridinium chloride substantially not absorbed through the oral mucosa. Lidocaine hydrochloride is poorly absorbed through the oral mucosa. When ingestion absorbed by undergoing metabolism in the “first pass” through the liver. The ingestion bioavailability is about 35%. Metabolites derived together with urine, at least 10% of the material displayed in unchanged form.
Pregnancy and breast-feeding
Not use this drug in Teraflyu® LAR Menthol I trimester because the drug penetrates the placental barrier. Application in II-III trimesters of pregnancy is possible under the supervision of a doctor, if the expected benefit to the mother outweighs the potential risk to the fetus. The drug is excreted in breast milk, so it is not recommended for use during breastfeeding.
Conditions of supply of pharmacies
Without recipe
side effects
Determination of the frequency of adverse reactions: very often (> 10%); frequent (> 1%, but
special instructions
The drug should not be taken immediately before the meal and at the same time with the milk. Simultaneous treatment with the drug with milk and food can reduce local antiseptic and anesthetic effects. Alcohol increases the absorption of cetylpyridinium chloride, so you should avoid drinking alcohol while taking the drug. Cetylpyridinium chloride slows wound healing. In one tablet contains 1107 mg of sorbitol as a sweetener, however Teraflyu® LAR Menthol should not accept patients with congenital fructose intolerance. Effects on ability to drive vehicles and management mechanisms are not affected.
Storage conditions
The drug should be kept out of reach of children at a temperature not higher than 30 ° C.
Dosing and Administration
The tablet should dissolve slowly in the mouth. Tablets should not be chewed or swallowed. Do not take TeraFlyu® LAR Menthol during or immediately before a meal. Adults and children over 12 years: 1 tablet. every 1-2 hours during acute inflammation and severe pain. When more light condition – on 1 tab. . Every 2-3 hours maximum daily dose – not more than 6 tab. Children 6 to 12 years: 1 tablet. every 3-4 hours as needed, the maximum daily dose – not more than 3 tablets. You should not use pills TeraFlyu® LAR Menthol more than 5 consecutive days. If symptoms persist or accompanied by high fever, dizziness and vomiting, it is necessary to stop taking the drug, and to consult with a physician.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist